Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 02, 2021 07:50 ET | Source: Arch Therapeutics, Inc.

Arch Therapeutics to Present at the LD Micro Invitational XI, June 8 - 10, 2021

FRAMINGHAM, Mass., June 02, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel self-assembling wound care and biosurgical devices, today...
May 10, 2021 07:50 ET | Source: Arch Therapeutics, Inc.

Arch Therapeutics’ AC5® Advanced Wound System Presents with Recognition at the 2021 Symposium on Advanced Wound Care (SAWC) Spring | Wound Healing Society (WHS)

FRAMINGHAM, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel self-assembling wound care and biosurgical devices, presents...
May 03, 2021 07:50 ET | Source: Arch Therapeutics, Inc.

Arch Therapeutics Appoints Michael S. Abrams its Chief Financial Officer

FRAMINGHAM, Mass., May 03, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel self-assembling wound care and biosurgical devices, today...
April 27, 2021 07:50 ET | Source: Arch Therapeutics, Inc.

Arch Therapeutics to Present AC5® Advanced Wound System at 2021 Symposium on Advanced Wound Care (SAWC)

FRAMINGHAM, Mass., April 27, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel self-assembling wound care and biosurgical devices, today...
April 19, 2021 07:50 ET | Source: Arch Therapeutics, Inc.

Arch Therapeutics Provides Corporate Update on Commercialization Efforts and Clinical Results

FRAMINGHAM, Mass., April 19, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel self-assembling wound care and biosurgical devices, today...
March 02, 2021 07:50 ET | Source: https://www.archtherapeutics.com/

Arch Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference, March 9-10, 2021

FRAMINGHAM, Mass., March 02, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), innovator of AC5® Advanced Wound System and other self-assembling Dermal...
February 18, 2021 07:50 ET | Source: Arch Therapeutics, Inc.

Arch Therapeutics Announces Closing of $6.9 Million Private Placement

FRAMINGHAM, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel self-assembling wound care and biosurgical devices, today...
February 12, 2021 00:45 ET | Source: Arch Therapeutics, Inc.

Arch Therapeutics Announces $6.9 Million Private Placement

FRAMINGHAM, Mass., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel self-assembling wound care and biosurgical devices, today...
January 05, 2021 07:55 ET | Source: Arch Therapeutics, Inc.

Arch Therapeutics to Present at the H.C. Wainwright BioConnect Conference, January 11 - 14, 2021

FRAMINGHAM, Mass., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel self-assembling wound care and biosurgical devices, announced...
January 04, 2021 07:50 ET | Source: Arch Therapeutics, Inc.

Arch Therapeutics Announces Distribution Agreement with Buffalo Supply, Inc.

FRAMINGHAM, Mass., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel self-assembling wound care and biosurgical devices, announced...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right